Acute Hepatic Porphyria Clinical Trial
Official title:
Prevalence of Acute Hepatic Porphyria in Population With Suggestive Clinical Picture
To determine the proportion of patients suffering from acute hepatic porphyria (AHP) from different hospital departments and referred to an internist referent for a suggestive clinical picture with a first negative etiological assessment.
In this context, this study aims to assess the prevalence of PHA in a population of patients with a suggestive clinical picture. A better knowledge of the pathology will make it possible to better guide patients and prevent them from diagnostic wandering fraught with physical and psychological consequences. This is an observational, ambispective, transversal, multicenter study carried out in France. The goal is to recruit a cohort that will reflect current practice. 500 patients will be recruted. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03338816 -
ENVISION: A Study to Evaluate the Efficacy and Safety of Givosiran (ALN-AS1) in Patients With Acute Hepatic Porphyrias (AHP)
|
Phase 3 | |
Terminated |
NCT03547297 -
INSIGHT-AHP: A Study to Characterize the Prevalence of Acute Hepatic Porphyria (AHP) in Patients With Clinical Presentation and History Consistent With AHP
|
||
Recruiting |
NCT05344599 -
Evaluating the Prevalence of Acute Hepatic Porphyria in Postural Tachycardia Syndrome
|
||
Completed |
NCT02240784 -
EXPLORE: A Natural History Study of Acute Hepatic Porphyria (AHP)
|
||
Recruiting |
NCT04883905 -
ELEVATE, a Registry of Patients With Acute Hepatic Porphyria (AHP)
|
||
Approved for marketing |
NCT04056481 -
Expanded Access Protocol of Givosiran for Patients With Acute Hepatic Porphyria
|